Prevalence, Risk Factors, and Comorbidities of Hidradenitis Suppurativa
Recommended Citation
Miller IM, McAndrew RJ, Hamzavi I. Prevalence, Risk Factors, and Comorbidities of Hidradenitis Suppurativa. Dermatologic clinics 2016; 34(1):7-16.
Document Type
Article
Publication Date
1-1-2016
Publication Title
Dermatologic clinics
Abstract
It is challenging to estimate a true prevalence of hidradenitis suppurativa (HS) because it is underdiagnosed and misdiagnosed. Prevalences have been reported from 0.00033% to 4.1%. The incidence seems to be rising. In addition to dermatologic symptoms, HS is associated with metabolic syndrome, and increased cardiovascular risk. The majority of HS patients are smokers. Additional somatic comorbidities complicating HS include autoimmune conditions, follicular syndromes, rheumatologic conditions, and malignancies. HS patients are troubled by psychological comorbidities. When treating HS patients it is imperative not only to treat the skin symptoms, but also address the screening and treatment of possible comorbidities.
Medical Subject Headings
Anxiety; Cardiovascular Diseases; Comorbidity; Depression; Diabetes Mellitus, Type 1; Hair Diseases; Hair Follicle; Hidradenitis Suppurativa; Humans; Metabolic Syndrome; Neoplasms; Prevalence; Rheumatic Diseases; Risk Factors; Smoking
PubMed ID
26617352
Volume
34
Issue
1
First Page
7
Last Page
16
